A metabolic profile of polyamines in parkinson disease: A promising biomarkerShinji Saiki, Nobutaka Hattori, Shin‐Ichi Ueno et al.|Annals of Neurology|2019Cited by 123
Serum caffeine and metabolites are reliable biomarkers of early Parkinson diseaseMotoki Fujimaki, Nobutaka Hattori, Yoshiki Miura et al.|Neurology|2018Cited by 103